美国草药现状及发展中药的若干看法

被引:3
作者
许家杰
机构
[1] 美国洛杉矶加州大学东西医学中心
关键词
草药; 食品; 畅销; 美国; 美利坚合众国; 北美洲; 补充剂;
D O I
暂无
中图分类号
F407.7 [化学工业];
学科分类号
020205 ; 0202 ;
摘要
引用
收藏
页码:926 / 928
页数:3
相关论文
共 16 条
[1]  
Efficacy, safety, quality control, marketing and regulatory guidelines for herbal medicines ( phytotherapeutic agents). Calixto JB. Brazilian Journal of Medical and Biological Research . 2000
[2]  
Drug store news picks the categories taking off in 1994. The Right Stuff. Drug Store News . 1994
[3]  
Cancer and herbs. Kessler DA. The New England Journal of Medicine . 2000
[4]  
Dietary supplements containing ephedra alkaloids. Traub SJ,Hoyek W,Hoffman RS. The New England Journal of Medicine . 2001
[5]  
Alternative medicinc———the risks of untested and unregulated remedies. Angell M,Kassirer JP. The New England Journal of Medicine . 1998
[6]  
Chinese Herbs and urothelial carcinoma. Shum S,Lu W,Li YM,et al. The New England Journal of Medicine . 2000
[7]  
Urothelial carcinoma associated with the use of a Chinese herb (Aristolochia fangchi). Nortier JL,Martinez MC,Schmeiser HH,et al. The New England Journal of Medicine . 2000
[8]  
FDAtoevaluatesupplementsafety. MartiStephens. IssueofNaturalFoodsMerchandiser . 2001
[9]  
KidneyproblemsassociatedwiththesubsitutionofChineseherbformulawitharistolochia. ChenJK. HerbClip . 2000
[10]  
Foodlabelingandnutrition. USFoodandDrugAdministrationCenterforFoodSafetyandAppliedNutrition. http://vm.cf san.fda.gov/label.huml .